CareCloud Inc美国股票招股说明书(2026年4月14日版)

CareCloud, Inc.Up to $60,000,000 We have entered into an At The Market Offering Agreement, dated April 13, 2026 (the “Offering Agreement”) with Citizens JMP Securities, LLC (“Citizens”) relatingto the sale of our common stock offered by this prospectus supplement and the accompanying base prospectus. In accordance with the terms of the Offering Agreement,under this prospectus supplement and the accompanying base prospectus we may offer and sell, from time to time, shares of common stock having an aggregateoffering price of up to $60 million, through or to Citizens, acting as agent or principal. Sales of common stock, if any, under this prospectus supplement will be made byany method permitted that is deemed an “at-the-market offering” as defined in Rule 415 under the Securities Act of 1933, as amended, or the “Securities Act”, includingsales made directly on or through the Nasdaq Global Market, the existing trading market for our common stock, sales made to or through a market maker other than onan exchange or otherwise, directly to Citizens as principal, in negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailing The compensation to Citizens for the sales of common stock sold under the Offering Agreement will be 3.0% of the gross sales price per share sold under the OfferingAgreement. The net proceeds, if any, that we receive from the sales of common stock will depend on the number of shares actually sold and the offering price for suchshares. See “Plan of Distribution” beginning on page S-11 for additional information regarding the compensation to be paid to Citizens. In connection with the sale of The aggregate market value of our common stock held by non-affiliates pursuant to General Instruction I.B.1 of Form S-3 is $111,401,277, which is based on36,169,246 shares of our outstanding common stock held by non-affiliates on April 8, 2026, and the closing price of our common stock on April 8, 2026, of $3.08 pershare. You should read this prospectus supplement in conjunction with the accompanying base prospectus, including any supplements and amendments thereto. Thisprospectus supplement is qualified by reference to the accompanying base prospectus except to the extent that the information in this prospectus supplement supersedes Our common stock currently trades on the Nasdaq Global Market, with the trading symbol “CCLD.” The last reported sale price of our common stock on April 10,2026 was $2.70 per share. Investing in our common stock involves significant risks. You should carefully consider the risk factors on page S-8 of this prospectus supplement, our 2025Annual Report on Form 10-K and in the documents incorporated herein by reference, before purchasing any of the common stock offered by this prospectussupplement. NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED ORDISAPPROVEDOF THESE SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THIS PROSPECTUSSUPPLEMENT OR THE PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. Citizens Capital Markets Prospectus Supplement dated April 14, 2026 TABLE OF CONTENTSProspectus SupplementPageAbout This Prospectus SupplementS-1Special Note Regarding Forward-Looking StatementsS-2Prospectus Supplement SummaryS-3The OfferingS-7Risk FactorsS-8Use of ProceedsS-9DilutionS-10Plan of DistributionS-11Legal MattersS-12ExpertsS-12Where You Can Find More InformationS-12Incorporation of Information by ReferenceS-13Disclosure of Commission Position on Indemnification for Securities Act LiabilitiesS-13ProspectusPageAbout This Prospectus1Special Note Regarding Forward-Looking Statements2Where You Can Find More Information4Incorporation of Certain Information by Reference4About CareCloud, Inc.5Risk Factors8Use of Proceeds8Description of our Capital Stock9Description of the Series A and Series B Preferred Stock13Description of Debt Securities21Description of Warrants23Description of Subscription Rights25Certain U.S. Federal Income Tax Considerations25Plan of Distribution26Legal Matters27Experts27S-i ABOUT THIS PROSPECTUS SUPPLEMENT You should carefully read this entire prospectus supplement and the accompanying base prospectus, including the information included and referred to under “RiskFactors” below, the information incorporated by reference in this prospectus supplement and in the accompanying base prospectus, and the financial statements and This prospectus supplement and the accompanying base prospectus form part of a registration statement on Form S-3 that we filed with the Securities and ExchangeCommission, or SEC, using a “shelf” registration process. This document contains two parts. The first part consists of this prospectus supplement, which provides youwith specific information about this offering. The second part, the accompanying base prospectus, provides more general information, some of which may not apply tothis offering. Generally, w